Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NovaBay Pharmaceuticals, Inc. NBY
$1.04
+$0.04 (4.03%)
На 18:01, 12 мая 2023
+284.62%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
1994731.00000000
-
week52high
12.60
-
week52low
0.94
-
Revenue
14404000
-
P/E TTM
0
-
Beta
2.73840800
-
EPS
-9.66000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Ascendiant Capital | Buy | Buy | 20 мая 2022 г. |
| Ladenburg Thalmann | Buy | 18 сент 2019 г. | |
| H.C. Wainwright | Neutral | Buy | 13 мар 2019 г. |
| Roth Capital | Neutral | Buy | 26 мар 2018 г. |
| Roth Capital | Buy | 05 июн 2017 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Kunin Jeffrey | D | 0 | 1 | 06 дек 2022 г. |
| Kunin Audrey | D | 0 | 1 | 06 дек 2022 г. |
| Kunin Jeffrey | D | 1 | 5960 | 21 ноя 2022 г. |
| Kunin Audrey | D | 1 | 5960 | 21 ноя 2022 г. |
| Kunin Jeffrey | D | 0 | 5960 | 21 ноя 2022 г. |
| Kunin Audrey | D | 0 | 5960 | 21 ноя 2022 г. |
| Hall Justin | A | 83172 | 10000 | 14 сент 2022 г. |
| Kunin Audrey | D | 208632 | 291368 | 14 сент 2022 г. |
| Kunin Jeffrey | D | 208632 | 291368 | 14 сент 2022 г. |
| WU MIJIA | D | 30000 | 30000 | 21 мая 2022 г. |
Новостная лента
NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023
Business Wire
04 мая 2023 г. в 06:50
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2023 after market close on Thursday, May 11, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time: Thursday, May 11, 4:30 p.m. ET / 1:30 p.m. PT Pre-Registration: Participants can pre-register for the conference call here: Callers who pre-regi.
Penny Stocks To Buy Now? 5 With Big News Today
PennyStocks
21 апр 2023 г. в 10:22
Penny stocks news sparks momentum in the stock market today. The post Penny Stocks To Buy Now?
NovaBay Pharmaceuticals, Inc. (NBY) Q4 2022 Earnings Call Transcript
Seeking Alpha
30 мар 2023 г. в 22:07
NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - Chief Executive Officer and General Counsel Tommy Law - Interim Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Welcome to the NovaBay Pharmaceuticals' 2022 Fourth Quarter and Full Year Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023
Business Wire
23 мар 2023 г. в 06:50
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2022 after market close on Thursday, March 30, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time: Thursday, March 30, 4:30 p.m. ET / 1:30 p.m.
NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
Business Wire
31 янв 2023 г. в 06:50
EMERYVILLE, Calif.--( BUSINESS WIRE )--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 2:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website.